- Home
- SWK vs PEN Comparison
SWK vs PEN Comparison
Compare SWK & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWK | PEN |
|---|---|---|
| Founded | 1843 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 10.9B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SWK | PEN |
|---|---|---|
| Price | $72.51 | $299.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 16 |
| Target Price | $92.25 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 1.5M | 479.9K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.58% | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | 2.90 | ★ 4.14 |
| Revenue | ★ $15,166,300,000.00 | $1,333,798,000.00 |
| Revenue This Year | $0.05 | $16.77 |
| Revenue Next Year | $3.01 | $14.12 |
| P/E Ratio | ★ $25.02 | $72.65 |
| Revenue Growth | N/A | ★ 14.61 |
| 52 Week Low | $53.91 | $221.26 |
| 52 Week High | $91.06 | $310.00 |
Technical Indicators
Market Signals| Indicator | SWK | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 60.67 | 67.77 |
| Support Level | $69.27 | $284.95 |
| Resistance Level | $72.20 | $298.69 |
| Average True Range (ATR) | 2.14 | 8.02 |
| MACD | 0.82 | 0.11 |
| Stochastic Oscillator | 91.22 | 91.50 |
Price Performance
Historical ComparisonAbout SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.